COVID-19 Antigen Test: Why Some Companies Still Rely on It as a Pillar of Prevention
Since the end of strict health measures, many assumed that screening tests would become a thing of the past. Yet, many businesses continue to integrate the COVID-19 antigen test into their prevention practices. Why? Because vigilance remains essential to protect employees, maintain business continuity, and strengthen team confidence.
1. COVID-19 Antigen Test: Overview and How It Works
The COVID-19 antigen test is a rapid screening tool that can detect the presence of the SARS-CoV-2 virus in just a few minutes. Unlike the PCR test, which must be analyzed in a lab, the antigen test is performed on-site using a simple nasal swab.
Differences from the PCR Test
- PCR: more sensitive but requires 24 to 48 hours for results.
- Antigen: results in 15 to 20 minutes, ideal for quick decisions.
Ease of Use
No heavy equipment or specialized personnel are required. HR teams or health and safety staff can easily administer the tests.
Proven Reliability
Trusted products such as the COVID-19 Artron antigen test provide high accuracy rates and are approved by Health Canada.
2. Why Continue Administering COVID-19 Tests in the Workplace?
Some may think the virus is no longer a major threat. However, cases still occur, and certain industries remain especially vulnerable.
Maintaining a Safe Environment
Companies that continue to administer the COVID-19 antigen test demonstrate their commitment to protecting the health of employees, clients, and partners.
Reducing the Risk of Outbreaks
A single undetected case can spread quickly in the workplace. Rapid screening helps contain the situation before it escalates.
Preserving Business Continuity
Production shutdowns, mass absences, and temporary closures are costly. Preventive testing helps reduce these disruptions.
3. Advantages of Regular Testing
The benefits go far beyond basic health prevention.
- Fast results: the COVID-19 antigen test delivers results in under 20 minutes.
- Detection of asymptomatic cases: many carriers don’t know they’re infected.
- Corporate social responsibility: shows the organization cares for its community.
- Lower indirect costs: fewer sick leaves, less disruption.
In short, the cost of a test is minimal compared to the financial losses caused by an outbreak.
4. COVID-19 Case Management: What Strategy Should Companies Adopt?
Even with preventive measures, cases can still arise. The COVID-19 antigen test should be part of a clear protocol.
Recommended Steps
- Immediately isolate the person who tested positive.
- Inform the team while maintaining confidentiality.
- Test close contacts to prevent further spread.
- Implement temporary remote work where possible.
Importance of a Clear Plan
Companies that react quickly reassure employees and minimize operational impacts.
5. The COVID-19 Antigen Test as a Long-Term Prevention Tool
Contrary to common belief, these tests are not just a temporary solution but a sustainable prevention tool.
- Integration in workplace health and safety (OHS): on the same level as CO2 detectors or personal protective equipment.
- Complementary measures: ventilation, regular disinfection, masks when necessary.
- Increased confidence: employees and clients feel safer.
The COVID-19 antigen test becomes a natural part of risk management—just like a fire extinguisher or first-aid kit.
6. Which Antigen Test Should Businesses Choose?
COVID-19 Artron Antigen Test
- Approved by Health Canada.
- Reliable and accurate, with results in 15 minutes.
- Easy to use, no specialized equipment required.
- Convenient format, suitable for both small and large organizations.
Why Choose Artron?
The COVID-19 Artron Antigen Test combines simplicity, speed, and reliability at an excellent price point. It stands out as the ideal solution for companies seeking to maintain an effective and sustainable screening program.
7. How to Integrate Testing Into HR and OHS Strategies
The COVID-19 antigen test should not be seen as a burden, but as a facilitating measure.
Best Practices
- Train HR or OHS teams to administer the tests.
- Establish a clear protocol (who tests, when, how).
- Communicate benefits to reassure employees.
- Plan supply to avoid shortages.
8. Trends and Perspectives: The Role of COVID-19 Tests in the Future of Work
Even if the pandemic is less visible in the media, the virus is still circulating. Testing remains a strategic tool.
- Key sectors: healthcare, food industries, essential services.
- New waves: in case of a more contagious variant, companies already equipped will have an advantage.
- Global prevention: the COVID-19 antigen test is part of a workplace culture that prioritizes employee health.
Q&A
1. Why continue administering COVID-19 tests in 2025?
Because the virus is still circulating and can cause mass absences in the workplace.
2. What’s the difference between an antigen test and a PCR test?
PCR is more sensitive but takes longer to process, while antigen delivers results in 15 minutes.
3. Are antigen tests still reliable against variants?
Yes, Health Canada–approved products such as Artron remain effective.
4. How long does it take to get results?
On average, 15 to 20 minutes.
5. What are the advantages of the COVID-19 antigen test for businesses?
Speed, detection of asymptomatic carriers, business continuity, and reduced financial risks.
Conclusion
The COVID-19 antigen test remains a pillar of prevention for many businesses. It enables rapid screening, limits outbreaks, and protects business continuity.
The COVID-19 Artron Antigen Test provide employers with a practical way to strengthen workplace health and safety strategies.
By investing in these simple, effective tools, organizations don’t just react—they anticipate, reassure, and protect their future.
About Stéphane Maurais – Founder of Alco Prevention Canada
Since 1989, Stéphane Maurais has embodied passion, innovation, and determination in the service of road safety and the prevention of risks related to alcohol and drug use. Alongside his partner Ronald Chartrand—whose father tragically lost his life in a traffic accident in the 1970s—he founded Alco Prevention Canada, now recognized as a global leader in prevention solutions. These include certified single-use breathalyzers, electronic breath alcohol testers, drug screening tests, workplace health and safety programs, and event-based prevention tools.
Over a 36-year career, Stéphane Maurais has distributed millions of breathalyzers, helped save thousands of lives, and raised awareness among companies, government agencies, law enforcement, colleges, and universities around the world. He is also a pioneer in the fight against chemical submission, developing concrete tools to combat date rape drugs.
His commitment is unwavering:
“Every breath measured is a life protected. For 36 years, my mission has been simple: to save lives, one decision at a time.”
— Stéphane Maurais
Founder and President, Alco Prevention Canada
